Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lewin

Showing results (281-290 of 331) with videos related to

Pageof 34
Sort By:
Behaviour Research and Therapy|November 5, 2013
Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorderEric A Storch, Regina Bussing, Brent J Small, et al.
Journal of the American Heart Association|May 23, 2020
Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart DiseaseTarek Alsaied, Jamil A Aboulhosn, Timothy B Cotts, et al.
Biological Psychiatry|September 7, 2010
A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorderEric A Storch, Tanya K Murphy, Wayne K Goodman, et al.
Journal of Affective Disorders|December 30, 2022
Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophoniaAndrew G Guzick, Matti Cervin, Eleanor E A Smith, et al.
Journal of Neuroimmunology|July 3, 2024
Evaluating the effect of dimethyl fumarate on subclinical biomarkers in a real-world patient cohortStephen Krieger, Myassar Zarif, Barbara Bumstead, et al.
Journal of Affective Disorders|December 1, 2023
Corrigendum to "Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia" [J. Affect. Disord. volume 324 (2023) 395-402]Andrew G Guzick, Matti Cervin, Eleanor E A Smith, et al.
Comprehensive Psychiatry|November 12, 2015
Defining clinical severity in adults with obsessive-compulsive disorderEric A Storch, Alessandro S De Nadai, Maria Conceição do Rosário, et al.
Multiple Sclerosis and Related Disorders|July 3, 2024
Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosisRiley Bove, Angela Applebee, Katrina Bawden, et al.
Pediatric Neurology|February 8, 2020
Tic Disorders are Associated With Lower Child and Parent Quality of Life and Worse Family FunctioningJennifer Vermilion, Erika Augustine, Heather R Adams, et al.
Neurology and Therapy|June 27, 2024
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 StudyBarry A Singer, Sibyl Wray, Mark Gudesblatt, et al.
Pageof 34

Showing results (281-290 of 331) with videos related to

Sort By:
Pageof 34
Behaviour Research and Therapy|November 5, 2013
Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorderEric A Storch, Regina Bussing, Brent J Small, et al.
Journal of the American Heart Association|May 23, 2020
Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart DiseaseTarek Alsaied, Jamil A Aboulhosn, Timothy B Cotts, et al.
Biological Psychiatry|September 7, 2010
A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorderEric A Storch, Tanya K Murphy, Wayne K Goodman, et al.
Journal of Affective Disorders|December 30, 2022
Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophoniaAndrew G Guzick, Matti Cervin, Eleanor E A Smith, et al.
Journal of Neuroimmunology|July 3, 2024
Evaluating the effect of dimethyl fumarate on subclinical biomarkers in a real-world patient cohortStephen Krieger, Myassar Zarif, Barbara Bumstead, et al.
Journal of Affective Disorders|December 1, 2023
Corrigendum to "Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia" [J. Affect. Disord. volume 324 (2023) 395-402]Andrew G Guzick, Matti Cervin, Eleanor E A Smith, et al.
Comprehensive Psychiatry|November 12, 2015
Defining clinical severity in adults with obsessive-compulsive disorderEric A Storch, Alessandro S De Nadai, Maria Conceição do Rosário, et al.
Multiple Sclerosis and Related Disorders|July 3, 2024
Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosisRiley Bove, Angela Applebee, Katrina Bawden, et al.
Pediatric Neurology|February 8, 2020
Tic Disorders are Associated With Lower Child and Parent Quality of Life and Worse Family FunctioningJennifer Vermilion, Erika Augustine, Heather R Adams, et al.
Neurology and Therapy|June 27, 2024
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 StudyBarry A Singer, Sibyl Wray, Mark Gudesblatt, et al.
Pageof 34